Open-House discount contracts 2026-15

Summary

The tender concerns Open-House discount contracts for medicines to be concluded with German health insurers. The contracts cover all eligible medicines listed in the respective lots in terms of active substances, combinations or dosage forms, and generally apply to all suitable pharmaceutical companies’ offerings. The contracts do not confer exclusivity to any participant; uniform terms apply. The contract duration is generally up to 24 months, starting no earlier than 01 November 2026 and ending no later than 31 October 2028 (subject to lot-specific variations). Participation and detailed conditions are described in the tender documents.